- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 206463, 10 pages
Interaction of Helicobacter pylori with C-Type Lectin Dendritic Cell-Specific ICAM Grabbing Nonintegrin
1Department of Immunology and Infectious Biology, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland
2Department of Microbiology, School of Natural Sciences, National University of Ireland Galway, University Road, Galway, Ireland
Received 2 November 2011; Revised 23 January 2012; Accepted 26 January 2012
Academic Editor: Nobutaka Wakamiya
Copyright © 2012 Eliza Miszczyk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- B. J. Marshall and J. R. Warren, “Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration,” The Lancet, vol. 1, no. 8390, pp. 1311–1314, 1984.
- M. Chmiela and P. Michetti, “Inflammation, immunity, vaccines for Helicobacter infection,” Helicobacter, vol. 11, pp. 21–26, 2006.
- J. E. Crabtree, “Mucosal immune responses to Helicobacter pylori,” European Journal of Gastroenterology and Hepatology, vol. 5, no. 2, pp. S30–S32, 1993.
- B. Gebert, W. Fischer, E. Weiss, R. Hoffmann, and R. Haas, “Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation,” Science, vol. 301, no. 5636, pp. 1099–1102, 2003.
- T. L. Cover and M. J. Blaser, “Helicobacter pylori in Health and Disease,” Gastroenterology, vol. 136, no. 6, pp. 1863–1873, 2009.
- B. Paziak-Domańska, M. Chmiela, A. Jarosińska, and W. Rudnicka, “Potential role of cagA in the inhibition of T cell reactivity in Helicobacter pylori infections,” Cellular Immunology, vol. 202, no. 2, pp. 136–139, 2000.
- J. Zabaleta, D. J. McGee, A. H. Zea et al., “Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR ζ-chain (CD3ζ),” Journal of Immunology, vol. 173, no. 1, pp. 586–593, 2004.
- M. S. Sundrud, V. J. Torres, D. Unutmaz, and T. L. Cover, “Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 20, pp. 7727–7732, 2004.
- M. Gerhard, C. Schmees, P. Voland et al., “A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells,” Gastroenterology, vol. 128, no. 5, pp. 1327–1339, 2005.
- V. J. Torres, S. E. VanCompernolle, M. S. Sundrud, D. Unutmaz, and T. L. Cover, “Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets,” Journal of Immunology, vol. 179, no. 8, pp. 5433–5440, 2007.
- Ch. Alexander and E. T. Rietschel, “Bacterial lipopolysaccharides and innate immunity,” Journal of Endotoxin Research, vol. 7, no. 3, pp. 167–202, 2001.
- A. Muotiala, I. M. Helander, L. Pyhala, T. U. Kosunen, and A. P. Moran, “Low biological activity of Helicobacter pylori lipopolysaccharide,” Infection and Immunity, vol. 60, no. 4, pp. 1714–1716, 1992.
- A. Grębowska, A. P. Moran, A. Matusiak et al., “Anti-phagocytic activity of Helicobacter pylori lipopolysaccharide (LPS)-possible modulation of the innate immune response to these bacteria,” Polish Journal of Microbiology, vol. 57, no. 3, pp. 185–192, 2008.
- A. Grębowska, A. P. Moran, W. Bielanski et al., “Helicobacter pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures,” Journal of Physiology and Pharmacology, vol. 61, no. 4, pp. 437–442, 2010.
- K. Rudnicka, M. Włodarczyk, A. P. Moran, et al., “Immunomodulatory activity of H. pylori LPS-possible reason of chronic infections,” Helicobacter, vol. 14, no. 4, p. 10, 2009.
- W. Rudnicka, A. Jarosinska, L. Bak-Romaniszyn et al., “Helicobacter pylori lipopolysaccharide in the IL-2 milieu activates lymphocytes from dyspeptic children,” FEMS Immunology and Medical Microbiology, vol. 36, no. 3, pp. 141–145, 2003.
- G. O. Aspinall, M. A. Monteiro, H. Pang, E. J. Walsh, and A. P. Moran, “Lipopolysaccharide of the Helicobacter pylori strains P466 and M019: structures of the O antigen and core oligosaccharide regions,” Biochemistry, vol. 35, no. 7, pp. 2498–2504, 1996.
- G. O. Aspinall, M. A. Monteiro, H. Pang, E. J. Walsh, and A. P. Moran, “Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions,” Biochemistry, vol. 35, no. 5, pp. 2489–2497, 1996.
- I. M. Simoons-Smit, B. J. Appelmelk, T. Verboom et al., “Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide,” Journal of Clinical Microbiology, vol. 34, no. 9, pp. 2196–2200, 1996.
- B. J. Appelmelk, B. Shiberu, C. Trinks et al., “Phase variation in Helicobacter pylori lipopolysaccharide,” Infection and Immunity, vol. 66, no. 1, pp. 70–76, 1998.
- M. A. Monteiro, P. Y. Zheng, B. Ho et al., “Expression of histo-blood group antigens by lipopolysaccharides of Helicobacter pylori strains from Asian hosts: the propensity to express type 1 blood-group antigens,” Glycobiology, vol. 10, no. 7, pp. 701–713, 2000.
- D. A. Rasko, M. Keelan, T. J. M. Wilson, and D. E. Taylor, “Lewis antigen expression by Helicobacter pylori,” Journal of Infectious Diseases, vol. 184, no. 3, pp. 315–321, 2001.
- N. J. Edwards, M. A. Monteiro, G. Faller et al., “Lewis X structures in the O antigen side-chain promote adhesion of Helicobacter pylori to the gastric epithelium,” Molecular Microbiology, vol. 35, no. 6, pp. 1530–1539, 2000.
- M. A. Heneghan, C. F. McCarthy, and A. P. Moran, “Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host Lewis phenotype and inflammatory response,” Infection and Immunity, vol. 68, no. 2, pp. 937–941, 2000.
- B. J. Appelmelk, I. Simoons-Smit, R. Negrini et al., “Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity,” Infection and Immunity, vol. 64, no. 6, pp. 2031–2040, 1996.
- A. Grȩbowska, T. Rechciński, A. Moran et al., “Increased levels of immunoglobuline and non-immunoglobuline markers of host response to H. pylori LPS in the patients with coronary artery disease (CAD),” Current Trends in Immunology, vol. 7, pp. 85–96, 2006.
- A. Cambi and C. G. Figdor, “Levels of complexity in pathogen recognition by C-type lectins,” Current Opinion in Immunology, vol. 17, no. 4, pp. 345–351, 2005.
- H. D. Brightbill and R. L. Modlin, “Toll-like receptors: molecular mechanisms of the mammalian immune response,” Immunology, vol. 101, no. 1, pp. 1–10, 2000.
- S. R. Krutzik, P. A. Sieling, and R. L. Modlin, “The role of Toll-like receptors in host defense against microbial infection,” Current Opinion in Immunology, vol. 13, no. 1, pp. 104–108, 2001.
- S. I. Miller, R. K. Ernst, and M. W. Bader, “LPS, TLR4 and infectious disease diversity,” Nature Reviews Microbiology, vol. 3, no. 1, pp. 36–46, 2005.
- F. Bäckhed, B. Rokbi, E. Torstensson et al., “Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4,” Journal of Infectious Diseases, vol. 187, no. 5, pp. 829–836, 2003.
- M. F. Smith Jr, A. Mitchell, G. Li et al., “Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-κB activation and chemokine expression by epithelial cells,” Journal of Biological Chemistry, vol. 278, no. 35, pp. 32552–32560, 2003.
- M. P. Bergman, A. Engering, H. H. Smits et al., “Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN,” Journal of Experimental Medicine, vol. 200, no. 8, pp. 979–990, 2004.
- T. B. H. Geijtenbeek, A. Engering, and Y. Van Kooyk, “DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology,” Journal of Leukocyte Biology, vol. 71, no. 6, pp. 921–931, 2002.
- E. J. Soilleux, L. S. Morris, G. Leslie et al., “Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro,” Journal of Leukocyte Biology, vol. 71, no. 3, pp. 445–457, 2002.
- A. Grębowska, A. P. Moran, E. Czkwianianc, et al., “A modulation of macrophage response to H. pylori LPS with or without Lewis XY determinants,” Helicobacter, vol. 9, no. 5, p. 16, 2004.
- W. Rudnicka, E. Czkwianianc, I. Płaneta-Małecka et al., “A potential double role of anti-Lewis X antibodies in Helicobacter pylori-associated gastroduodenal diseases,” FEMS Immunology and Medical Microbiology, vol. 30, no. 2, pp. 121–125, 2001.
- A. P. Moran, I. M. Helander, and T. U. Kosunen, “Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides,” Journal of Bacteriology, vol. 174, no. 4, pp. 1370–1377, 1992.
- T. B. H. Geijtenbeek, D. S. Kwon, R. Torensma et al., “DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells,” Cell, vol. 100, no. 5, pp. 587–597, 2000.
- Y. van Kooyk and T. B. H. Geijtenbeek, “DC-SIGN: escape mechanism for pathogens,” Nature Reviews Immunology, vol. 3, no. 9, pp. 697–709, 2003.
- I. S. Ludwig, A. N. Lekkerkerker, E. Depla et al., “Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation,” Journal of Virology, vol. 78, no. 15, pp. 8322–8332, 2004.
- S. Ehlers, “DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison,” European Journal of Cell Biology, vol. 89, no. 1, pp. 95–101, 2010.
- H. Feinberg, D. A. Mitchell, K. Drickamer, and W. I. Weis, “Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR,” Science, vol. 294, no. 5549, pp. 2163–2166, 2001.
- Y. Guo, H. Feinberg, E. Conroy et al., “Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR,” Nature Structural and Molecular Biology, vol. 11, no. 7, pp. 591–598, 2004.
- E. van Liempt, C. M. C. Bank, P. Mehta et al., “Specificity of DC-SIGN for mannose- and fucose-containing glycans,” FEBS Letters, vol. 580, no. 26, pp. 6123–6131, 2006.
- V. Bogoevska, A. Horst, B. Klampe, L. Lucka, C. Wagener, and P. Nollau, “CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via Lewis x residues,” Glycobiology, vol. 16, no. 3, pp. 197–209, 2006.
- J. Klena, P. Zhang, O. Schwartz, S. Hull, and T. Chen, “The core lipopolysaccharide of Escherichia coli is a ligand for the dendritic-cell-specific intercellular adhesion molecule nonintegrin CD209 receptor,” Journal of Bacteriology, vol. 187, no. 5, pp. 1710–1715, 2005.
- D. A. Mitchell, A. J. Fadden, and K. Drickamer, “A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands,” Journal of Biological Chemistry, vol. 276, no. 31, pp. 28939–28945, 2001.
- A. R. Kolatkar and W. I. Weis, “Structural basis of galactose recognition by C-type animal lectins,” Journal of Biological Chemistry, vol. 271, no. 12, pp. 6679–6685, 1996.
- J. Geurtsen, S. Chedammi, J. Mesters et al., “Identification of mycobacterial α-glucan as a novel ligand for DC-SIGN: involvement of mycobacterial capsular polysaccharides in host immune modulation,” Journal of Immunology, vol. 183, no. 8, pp. 5221–5231, 2009.
- A. Puig-Kröger, D. Serrano-Gomez, E. Caparros, et al., “Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonitegrin in THP-1 human leukemic cells, monocytes and macrophages,” The Journal of Biological Chemistry, vol. 279, no. 24, pp. 25680–25688, 2004.
- G. I. Perez-Perez, V. L. Shepherd, J. D. Morrow, and M. J. Blaser, “Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide,” Infection and Immunity, vol. 63, no. 4, pp. 1183–1187, 1995.
- W. K. Chan, C. C. Cheung, H. K. Law, Y. L. Lau, and G. C. Chan, “Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function,” Journal of Hematology & Oncology, vol. 1, p. 9, 2008.
- V. Bogoevska, P. Nollau, L. Lucka et al., “DC-SIGN binds ICAM-3 isolated from peripheral human leukocytes through Lewis x residues,” Glycobiology, vol. 17, no. 3, pp. 324–333, 2007.